Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors

Galectin-8 (Gal-8) is a 'tandem-repeat'-type galectin, which possesses two carbohydrate recognition domains connected by a linker peptide. Gal-8 complexity is related to the alternative splicing of its mRNA precursor, which is known to generate isoforms. Regarding its carbohydrate-binding...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Elola, M.T., Ferragut, F., Cárdenas Delgado, V.M., Nugnes, L.G., Gentilini, L., Laderach, D., Troncoso, M.F., Compagno, D., Wolfenstein-Todel, C., Rabinovich, G.A.
Formato:	JOUR
Materias:	Galectin-8 Isoforms Lung Prostate Tumors galectin LGALS8 protein, human tumor marker human metabolism neoplasm pathology Galectins Humans Neoplasms Tumor Markers, Biological
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_02133911_v29_n9_p1093_Elola
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors
Publicado: (2014)

Glycans and galectins in prostate cancer biology, angiogenesis and metastasis
por: Compagno, D., et al.

Galectin-8: A matricellular lectin with key roles in angiogenesis
por: Troncoso, M.F., et al.

Glycans and galectins in prostate cancer biology, angiogenesis and metastasis
Publicado: (2014)

Vascular galectins: Regulators of tumor progression and targets for cancer therapy
Publicado: (2013)

Vascular galectins: Regulators of tumor progression and targets for cancer therapy
por: Thijssen, V.L., et al.

Galectin-8: A matricellular lectin with key roles in angiogenesis
por: Troncoso, María Fernanda, et al.
Publicado: (2014)

Defining the fate and function of effector T cells through galectin-1-galectin-1 ligand-binding interactions: Implications in tumor immunity
Publicado: (2014)

Defining the fate and function of effector T cells through galectin-1-galectin-1 ligand-binding interactions: Implications in tumor immunity
por: Dimitroff, C.J., et al.

Modulation of endothelial cell migration and angiogenesis: A novel function for the "tandem-repeat" lectin galectin-8
por: Cárdenas Delgado, V.M., et al.

Introduction to special issue: Galectins go with the flow
Publicado: (2014)

Introduction to special issue: Galectins go with the flow
por: Rabinovich, G.A., et al.

Galectins in hematological malignancies
por: Giordano, M., et al.

A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease
por: Laderach, D.J., et al.

Galectins in hematological malignancies
Publicado: (2013)

Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings
por: Laderach, D.J., et al.
Publicado: (2010)

Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings
por: Laderach, D.J., et al.

Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings
por: Laderach, D.J., et al.
Publicado: (2010)

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
por: Corapi, E., et al.

Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
por: Elola, M.T., et al.

Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma
por: Vase, M., et al.

Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, D., et al.

Modulation of endothelial cell migration and angiogenesis: A novel function for the "tandem-repeat" lectin galectin-8
por: Troncoso, María Fernanda, et al.
Publicado: (2011)

Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma
Publicado: (2017)

Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer
por: Salatino, M., et al.

A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease
Publicado: (2013)

Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer
Publicado: (2008)

Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings
por: Toscano, Marta Alicia, et al.
Publicado: (2010)

Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
Publicado: (2018)

'Sweetening' Pregnancy: Galectins at the Fetomaternal Interface
por: Blidner, Ada G.
Publicado: (2013)

'Sweetening' Pregnancy: Galectins at the Fetomaternal Interface
por: Blidner, A.G., et al.
Publicado: (2013)

'Sweetening' Pregnancy: Galectins at the Fetomaternal Interface
por: Blidner, A.G., et al.

'Sweetening' Pregnancy: Galectins at the Fetomaternal Interface
por: Blidner, A.G., et al.
Publicado: (2013)

Glycobiology of cell death: When glycans and lectins govern cell fate
Publicado: (2013)

Glycobiology of cell death: When glycans and lectins govern cell fate
por: Lichtenstein, R.G., et al.

Turning 'sweet' on immunity: Galectin-glycan interactions in immune tolerance and inflammation
por: Rabinovich, G.A., et al.

Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis
Publicado: (2017)

Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis
por: Méndez-Huergo, S.P., et al.

Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth
por: Ferragut, F., et al.

Turning 'sweet' on immunity: Galectin-glycan interactions in immune tolerance and inflammation
Publicado: (2009)